Core Viewpoint - Hema Medical (03309.HK) announced a share buyback of approximately HKD 537,100 for 300,000 shares at a price range of HKD 1.77-1.81 per share, indicating a strategic move to enhance shareholder value [1] Company Summary - As of November 4, 2025, Hema Medical's stock closed at HKD 1.81, down 0.55%, with a trading volume of 936,000 shares and a turnover of HKD 1.6597 million [1] - The company has a market capitalization of HKD 2.259 billion, ranking 15th in the medical services sector [1] Industry Summary - Hema Medical's key financial metrics compared to the industry average are as follows: - Return on Equity (ROE): -6.36% vs. industry average of -0.02%, ranking 39th [1] - Market capitalization: HKD 2.259 billion vs. industry average of HKD 7.906 billion, ranking 15th [1] - Revenue: HKD 1.935 billion vs. industry average of HKD 3.832 billion, ranking 15th [1] - Net Profit Margin: 5.95% vs. industry average of -843.36%, ranking 25th [1] - Gross Profit Margin: 31.12% vs. industry average of 39.76%, ranking 28th [1] - Debt Ratio: 29.8% vs. industry average of 74.15%, ranking 21st [1] - There has been low attention from investment banks, with no ratings given in the past 90 days [1]
希玛医疗(03309.HK)11月4日斥资约53.71万港元回购30万股